162 related articles for article (PubMed ID: 34520958)
21. Autocitrullination of PAD4 does not alter its enzymatic activity: In vitro and in silico studies.
Liu X; Wichapong K; Lamers S; Reutelingsperger CPM; Nicolaes GAF
Int J Biochem Cell Biol; 2021 May; 134():105938. PubMed ID: 33529715
[TBL] [Abstract][Full Text] [Related]
22. Regulation of p53 target gene expression by peptidylarginine deiminase 4.
Li P; Yao H; Zhang Z; Li M; Luo Y; Thompson PR; Gilmour DS; Wang Y
Mol Cell Biol; 2008 Aug; 28(15):4745-58. PubMed ID: 18505818
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of Peptidyl Arginine Deiminase-4 Prevents Renal Ischemia-Reperfusion-Induced Remote Lung Injury.
Du M; Yang L; Gu J; Wu J; Ma Y; Wang T
Mediators Inflamm; 2020; 2020():1724206. PubMed ID: 33456369
[TBL] [Abstract][Full Text] [Related]
24. MiR-155 Regulates PAD4-Dependent Formation of Neutrophil Extracellular Traps.
Hawez A; Al-Haidari A; Madhi R; Rahman M; Thorlacius H
Front Immunol; 2019; 10():2462. PubMed ID: 31736940
[TBL] [Abstract][Full Text] [Related]
25. PADs and NETs in digestive system: From physiology to pathology.
Song YH; Wang ZJ; Kang L; He ZX; Zhao SB; Fang X; Li ZS; Wang SL; Bai Y
Front Immunol; 2023; 14():1077041. PubMed ID: 36761761
[TBL] [Abstract][Full Text] [Related]
26. Thioredoxin Modulates Protein Arginine Deiminase 4 (PAD4)-Catalyzed Citrullination.
Nagar M; Tilvawala R; Thompson PR
Front Immunol; 2019; 10():244. PubMed ID: 30853960
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of protein arginine deiminase-4 inhibitor in TNBS- induced colitis in mice.
Zhang T; Mei Y; Dong W; Wang J; Huang F; Wu J
Int Immunopharmacol; 2020 Jul; 84():106583. PubMed ID: 32416455
[TBL] [Abstract][Full Text] [Related]
28. Protein arginine deiminase 4 inactivates tissue factor pathway inhibitor-alpha by enzymatic modification of functional arginine residues.
Thomassen MCLGD; Bouwens BRC; Wichapong K; Suylen DP; Bouwman FG; Hackeng TM; Koenen RR
J Thromb Haemost; 2023 May; 21(5):1214-1226. PubMed ID: 36716968
[TBL] [Abstract][Full Text] [Related]
29. Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.
Uysal-Onganer P; D'Alessio S; Mortoglou M; Kraev I; Lange S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573274
[TBL] [Abstract][Full Text] [Related]
30. Protein Arginine Deiminases (PADs): Biochemistry and Chemical Biology of Protein Citrullination.
Mondal S; Thompson PR
Acc Chem Res; 2019 Mar; 52(3):818-832. PubMed ID: 30844238
[TBL] [Abstract][Full Text] [Related]
31. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
32. Peptidyl arginine deiminase-4 exacerbates ischemic AKI by finding NEMO.
Rabadi MM; Han SJ; Kim M; D'Agati V; Lee HT
Am J Physiol Renal Physiol; 2019 Jun; 316(6):F1180-F1190. PubMed ID: 30943066
[TBL] [Abstract][Full Text] [Related]
33. PAD4 Deficiency Improves Bleomycin-induced Neutrophil Extracellular Traps and Fibrosis in Mouse Lung.
Suzuki M; Ikari J; Anazawa R; Tanaka N; Katsumata Y; Shimada A; Suzuki E; Tatsumi K
Am J Respir Cell Mol Biol; 2020 Dec; 63(6):806-818. PubMed ID: 32915635
[TBL] [Abstract][Full Text] [Related]
34. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Knuckley B; Luo Y; Thompson PR
Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
[TBL] [Abstract][Full Text] [Related]
35. PAD4-dependent citrullination of nuclear translocation of GSK3β promotes colorectal cancer progression via the degradation of nuclear CDKN1A.
Luo X; Chang S; Xiao S; Peng Y; Gao Y; Hu F; Liang J; Xu Y; Du K; Chen Y; Qin J; Meltzer SJ; Deng S; Feng X; Fan X; Hou G; Jin Z; Zhang X
Neoplasia; 2022 Nov; 33():100835. PubMed ID: 36113195
[TBL] [Abstract][Full Text] [Related]
36. Activation of PAD4 in NET formation.
Rohrbach AS; Slade DJ; Thompson PR; Mowen KA
Front Immunol; 2012; 3():360. PubMed ID: 23264775
[TBL] [Abstract][Full Text] [Related]
37. Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.
Wang S; Wang Y
Biochim Biophys Acta; 2013 Oct; 1829(10):1126-35. PubMed ID: 23860259
[TBL] [Abstract][Full Text] [Related]
38. Modulating neutrophil extracellular traps for wound healing.
Kaur T; Dumoga S; Koul V; Singh N
Biomater Sci; 2020 Jun; 8(11):3212-3223. PubMed ID: 32374321
[TBL] [Abstract][Full Text] [Related]
39. Protein arginine deiminase 4 (PAD4): Current understanding and future therapeutic potential.
Jones JE; Causey CP; Knuckley B; Slack-Noyes JL; Thompson PR
Curr Opin Drug Discov Devel; 2009 Sep; 12(5):616-27. PubMed ID: 19736621
[TBL] [Abstract][Full Text] [Related]
40. Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury.
Ham A; Rabadi M; Kim M; Brown KM; Ma Z; D'Agati V; Lee HT
Am J Physiol Renal Physiol; 2014 Nov; 307(9):F1052-62. PubMed ID: 25164081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
